PMEF
OGN icon

Point72 Middle East FZE’s Organon & Co OGN Stock Holding History

Point72 Middle East FZE’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-262
Closed -$4.55K – 1771
2023
Q3 		$4.55K Buy
+262
New +$5.46K ﹤0.01% 1377
2023
Q1 		– Sell
-7,660
Closed -$214K – 2043
2022
Q4 		$214K Buy
+7,660
New +$196K 0.01% 1027

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Point72 Middle East FZE's OGN Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 262 shares — an estimated $4.55K sold.

Point72 Middle East FZE first reported a position in OGN in Q4 2022 and held it in 2 quarters. The position peaked at $214K in Q4 2022. 718 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 262 Organon & Co shares in Q4 2023, an estimated $4.55K.
  • Point72 Middle East FZE first reported a position in Organon & Co in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Organon & Co position peaked at $214K in Q4 2022.
  • 718 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.